Literature DB >> 6524875

The induction and reversibility of cerebral acidosis in thiamine deficiency.

A M Hakim.   

Abstract

Regional cerebral pH was determined autoradiographically using carbon 14-labeled dimethyloxazolidinedione in normal rats, following various durations of thiamine deficiency and replenishment with thiamine when the clinical sequelae of the deficiency appeared. In our model the clinical sequelae of thiamine deficiency (opisthotonus) appeared on the average on day 18. Regional cerebral pH on day 12 was comparable to that in controls and ranged between 7.02 +/- 0.03 and 7.09 +/- 0.03 (mean +/- SEM) in gray matter structures. On day 14 the pH in the inferior colliculus was 6.85 +/- 0.08 and relative acidosis also appeared in thalamic structures. At opisthotonus the pH was 6.48 +/- 0.17 in the mamillary body, 6.43 +/- 0.14 in the vestibular nucleus, and 6.36 +/- 0.14 in the medial dorsal nucleus of the thalamus (p less than 0.01). One dose of thiamine replenishment at this stage transiently raised the pH in the inferior colliculus to 7.25 +/- 0.19 and in the medial dorsal nucleus to 7.20 +/- 0.13 (p less than 0.01). Cerebral regions showing significant acidosis during thiamine deficiency coincided largely with those known to be histologically vulnerable and those previously reported to show a focal rise in local cerebral glucose utilization between days 11 and 14 of thiamine deficiency. This focal acidosis shown to occur in thiamine deficiency may be one mechanism contributing to the selective histological vulnerability in this model.

Entities:  

Mesh:

Year:  1984        PMID: 6524875     DOI: 10.1002/ana.410160609

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  26 in total

Review 1.  The blood-brain barrier and selective vulnerability in experimental thiamine-deficiency encephalopathy in the mouse.

Authors:  N Harata; Y Iwasaki
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 2.  Mechanisms of neuronal cell death in Wernicke's encephalopathy.

Authors:  A S Hazell; K G Todd; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

Review 3.  Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Authors:  Eman Abdou; Alan S Hazell
Journal:  Neurochem Res       Date:  2014-10-09       Impact factor: 3.996

4.  Pyrithiamine-induced thiamine deficiency results in decreased Ca(2+)-dependent release of glutamate from rat hippocampal slices.

Authors:  O Lê; M Héroux; R F Butterworth
Journal:  Metab Brain Dis       Date:  1991-09       Impact factor: 3.584

5.  Regional glucose utilization and blood flow in experimental brain tumors studied by double tracer autoradiography.

Authors:  A Kato; K Sako; M Diksic; Y L Yamamoto; W Feindel
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

Review 6.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 7.  Pathogenesis of diencephalic lesions in an experimental model of Wernicke's encephalopathy.

Authors:  P J Langlais
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 8.  Neuronal cell death in Wernicke's encephalopathy: pathophysiologic mechanisms and implications for PET imaging.

Authors:  D K Leong; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

9.  Early axonal lesion and preserved microvasculature in epilepsy-induced hypermetabolic necrosis of the substantia nigra.

Authors:  R N Auer; M Ingvar; G Nevander; Y Olsson; B K Siesjö
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Depletion of brain histamine produces regionally selective protection against thiamine deficiency-induced lesions in the rat.

Authors:  Philip J Langlais; Robert Carter McRee; Julia A Nalwalk; Lindsay B Hough
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.